| HOME >> BIOLOGY >> TECHNOLOGY |
October 31, October 31,
2007 2006 2007 2006
Revenues:
Product sales $79,025 $63,809 $292,549 $255,838
Contract manufacturing
sales 2,995 3,377 14,264 14,816
Total revenues 82,020 67,186 306,813 270,654
Cost of revenues:
Cost of product sales,
including idle
capacity costs 46,364 40,625 179,367 158,600
Cost of contract
manufacturing sales 2,656 3,917 13,952 14,676
Total cost of
revenues 49,020 44,542 193,319 173,276
Gross margin 33,000 22,644 113,494 97,378
Operating expenses:
Research and
development 6,852 6,854 26,081 24,823
Selling, general and
administrative 13,659 10,149 50,185 41,614
Restructuring charge 106 4,729 853 4,729
Other operating
expenses 362 475 1,614 1,158
Total operating
expenses 20,979 22,207 78,733 72,324
Income from operations 12,021 437 34,761 25,054
Interest and other, net 73 (275) (1,089) (1,528)
Income before income
tax (benefit) provision 12,094 162 33,672 23,526
Income tax (benefit)
provision (6,174) 60 1,659 8,588
Net income $18,268 $102 $32,013 $14,938
Basic earnings
per share $0.56 $0.00 $0.99 $0.47
'/>"/>
| SOURCE Martek Biosciences Corporation Copyright©2007 PR Newswire. All rights reserved |